Literature DB >> 8346156

Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression.

M E Cook1, C C Miller, Y Park, M Pariza.   

Abstract

The ability of conjugated isomers of linoleic acid (CLA) to prevent reduced growth rate following endotoxin (lipopolysaccharide, LPS) injection was studied in two chick trials and one rat trial. Chicks (10 per treatment) were fed a corn and soybean meal-based diet with or without .5% CLA. At 21 days of age, chicks were weighed and injected i.p. with 1 mg/kg BW Escherichia coli LPS and sterile PBS. Body weights were again determined 24 h later. Antibody responses to SRBC were also determined. Rats fed .5% stearic acid or CLA for 4 wk (seven per treatment) were also injected with LPS, and BW change over a 24-h postinjection period was determined. Antibody responses to BSA, phytohemagglutinin foot pad swelling, and phagocytosis of elicited peritoneal macrophages were also determined. The CLA had no adverse effects on any immune variables measured in the chicks and rats. The CLA enhanced the phytohemagglutinin response and macrophage phagocytosis in rats. Chicks fed CLA and injected with LPS continued to grow, whereas those not fed CLA either failed to grow or lost weight following LPS injection. Both control and CLA-fed rats lost weight over the 24-h period after LPS injection; however, the loss of weight in rats fed CLA was only half of the weight loss of the control rats. Thus, CLA is effective in preventing the catabolic effects of immune stimulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346156     DOI: 10.3382/ps.0721301

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  39 in total

1.  Dietary supplementation with conjugated linoleic acid does not alter the resistance of mice to Listeria monocytogenes infection.

Authors:  L Turnock; M Cook; H Steinberg; C Czuprynski
Journal:  Lipids       Date:  2001-02       Impact factor: 1.880

2.  Dietary CLA alters yolk and tissue FA composition and hepatic histopathology of laying hens.

Authors:  Gita Cherian; Troy B Holsonbake; Mary P Goeger; Rob Bildfell
Journal:  Lipids       Date:  2002-08       Impact factor: 1.880

3.  Effect of conjugated linoleic acid on body composition in mice.

Authors:  Y Park; K J Albright; W Liu; J M Storkson; M E Cook; M W Pariza
Journal:  Lipids       Date:  1997-08       Impact factor: 1.880

Review 4.  Lipids in human milk.

Authors:  R G Jensen
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

Review 5.  Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies.

Authors:  Jean-Michel Gaullier; Grethe Berven; Henrietta Blankson; Ola Gudmundsen
Journal:  Lipids       Date:  2002-11       Impact factor: 1.880

6.  Similar effects of c9,t11-CLA and t10,c12-CLA on immune cell functions in mice.

Authors:  D S Kelley; J M Warren; V A Simon; G Bartolini; B E Mackey; K L Erickson
Journal:  Lipids       Date:  2002-07       Impact factor: 1.880

7.  Positional distribution of CLA in TAG of lamb tissues.

Authors:  Lyn J Paterson; Randall J Weselake; Priya S Mir; Zahir Mir
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

Review 8.  Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks.

Authors:  D S Kelley; K L Erickson
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

9.  Protective action of CLA against oxidative inactivation of paraoxonase 1, an antioxidant enzyme.

Authors:  Nguyen-Duy Su; Xi-Wen Liu; Mee Ree Kim; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2003-06       Impact factor: 1.880

10.  Isomer specificity of conjugated linoleic acid (CLA): 9E,11E-CLA.

Authors:  Yunkyoung Lee
Journal:  Nutr Res Pract       Date:  2008-12-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.